|
|
|
Volumn 2, Issue 1, 2000, Pages 7-8
|
|
New paradigms in the treatment of heart failure and arrhythmia
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALDOSTERONE ANTAGONIST;
ANGIOTENSIN RECEPTOR ANTAGONIST;
ANTIARRHYTHMIC AGENT;
AZIMILIDE;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM ANTAGONIST;
CALCIUM SENSITIZER;
CONIVAPTAN;
DIGOXIN;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
DOFETILIDE;
DRONEDARONE;
ETANERCEPT;
FLECAINIDE;
IBUTILIDE;
INOTROPIC AGENT;
IRBESARTAN;
LEVOSIMENDAN;
LIXIVAPTAN;
LOSARTAN;
MCC 135;
SOTALOL;
UNCLASSIFIED DRUG;
VALSARTAN;
VASODILATOR AGENT;
VASOPRESSIN RECEPTOR ANTAGONIST;
BRADYCARDIA;
CLINICAL PRACTICE;
CLINICAL TRIAL;
COMORBIDITY;
CONGESTIVE HEART FAILURE;
COST EFFECTIVENESS ANALYSIS;
DRUG EFFECT;
DRUG EFFICACY;
DRUG SAFETY;
EDITORIAL;
HEART ARRHYTHMIA;
HEART ATRIUM FIBRILLATION;
HEART ATRIUM FLUTTER;
HUMAN;
LUNG FIBROSIS;
QUALITY OF LIFE;
TORSADE DES POINTES;
TREATMENT OUTCOME;
|
|
EID: 0034054389
PISSN: 14648482
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
|
Times cited : (2)
|
|
References (0)
|
